Upexi Inc. (UPXI) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3030 ROCKY POINT DRIVE TAMPA, FL 33607 |
| State of Incorp. | NV |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2025 MRQ | 12/31/2024 MRQ | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 4,492 | 7,150 | 14,534 | |||||
| Cash and cash equivalent | 4,492 | 7,150 | 14,534 | |||||
| Receivables | 1,162 | 607 | 7,164 | 2,155 | 1,278 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,236 | 1,432 | 11,557 | 6,454 | 2,095 | |||
| Inventory | 2,236 | 1,432 | 11,557 | 6,454 | 2,095 | |||
| Disposal group, including discontinued operation | 90 | |||||||
| Intangible current assets | 717 | |||||||
| Other undisclosed current assets | 2,712 | 9,381 | 1,436 | 1,302 | 386 | |||
| Total current assets: | 6,110 | 11,420 | 25,456 | 17,062 | 18,293 | |||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 2,080 | 2,419 | 411 | 927 | 417 | |||
| Property, plant and equipment | 2,140 | 2,357 | 7,526 | 8,046 | 2,832 | |||
| Intangible assets, net (including goodwill) | 1,050 | 1,089 | 23,823 | 20,353 | 4,259 | |||
| Goodwill | 849 | 849 | 10,251 | 8,301 | 2,414 | |||
| Intangible assets, net (excluding goodwill) | 201 | 240 | 13,572 | 12,052 | 1,845 | |||
| Deferred income tax assets | 5,949 | 5,949 | ||||||
| Other noncurrent assets | 200 | 278 | 97 | 100 | 49 | |||
| Other undisclosed noncurrent assets | 6,540 | 2,003 | 1,404 | |||||
| Total noncurrent assets: | 11,419 | 12,091 | 38,397 | 31,429 | 8,961 | |||
| TOTAL ASSETS: | 17,529 | 23,511 | 63,853 | 48,491 | 27,255 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 1,227 | 1,218 | 7,335 | 4,248 | 3,052 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 148 | 10 | ||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 121 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 557 | 1,021 | ||
| Accounts payable | 1,005 | 482 | 3,970 | 2,591 | 1,605 | |||
| Accrued liabilities | 222 | 736 | 3,366 | 952 | 296 | |||
| Deferred revenue | 139 | 235 | 335 | 486 | ||||
| Debt | 280 | 2,731 | 5,425 | 447 | ||||
| Other undisclosed current liabilities | 8,971 | 11,202 | 9,539 | 120 | 1,834 | |||
| Total current liabilities: | 10,617 | 12,655 | 19,606 | 10,128 | 5,819 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 280 | 500 | 896 | 700 | 217 | |||
| Long-term debt, excluding current maturities | 280 | 500 | 896 | |||||
| Liabilities, other than long-term debt | 1,902 | 2,469 | 163 | 680 | (680) | |||
| Accounts payable and accrued liabilities | 57 | 736 | ||||||
| Other liabilities | 680 | (680) | ||||||
| Operating lease, liability | 1,844 | 1,733 | 163 | 700 | 217 | |||
| Other undisclosed noncurrent liabilities | 968 | 1,371 | 15,351 | 8,196 | 680 | |||
| Total noncurrent liabilities: | 3,149 | 4,340 | 16,410 | 9,577 | 217 | |||
| Total liabilities: | 13,766 | 16,995 | 36,016 | 19,704 | 6,037 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | 3,763 | 6,516 | 27,837 | 28,787 | 21,218 | |||
| Preferred stock | 0 | 0 | 1 | 1 | 1 | |||
| Common stock | 1 | 20 | 17 | 15 | ||||
| Additional paid in capital | 53,548 | 53,374 | 51,522 | 34,986 | 25,372 | |||
| Accumulated deficit | (49,787) | (46,860) | (23,201) | (6,271) | (4,170) | |||
| Other undisclosed equity, attributable to parent | 1 | (505) | 55 | |||||
| Total equity: | 3,763 | 6,516 | 27,837 | 28,787 | 21,218 | |||
| TOTAL LIABILITIES AND EQUITY: | 17,529 | 23,511 | 63,853 | 48,491 | 27,255 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | ||
|---|---|---|---|---|---|---|---|
| Revenues | (10,779) | 26,001 | 80,677 | 44,585 | 24,095 | ||
| Revenues, excluding interest and dividends | 4,005 | ||||||
| Cost of revenue | 15,669 | (13,176) | (47,118) | (19,396) | (12,196) | ||
| Gross profit: | 4,891 | 12,825 | 33,558 | 25,189 | 11,899 | ||
| Operating expenses | (26,735) | (35,287) | (41,110) | (27,841) | (10,472) | ||
| Operating income (loss): | (21,844) | (22,462) | (7,552) | (2,652) | 1,427 | ||
| Nonoperating income (expense) | (5,610) | (3,141) | (10,919) | (88) | 73 | ||
| Debt instrument, convertible, beneficial conversion feature | 343 | ||||||
| Other nonoperating expense | (5,610) | (3,141) | (10,919) | (88) | (269) | ||
| Interest and debt expense | (35) | (132) | (14) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 308 | 210 | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (27,455) | (25,604) | (18,506) | (2,564) | 1,696 | ||
| Other undisclosed income from continuing operations before income taxes | 3,901 | 35 | |||||
| Income (loss) from continuing operations before income taxes: | (23,553) | (25,604) | (18,471) | (2,564) | 1,696 | ||
| Income tax expense (benefit) | 835 | (332) | (3,049) | (518) | (1,283) | ||
| Income (loss) from continuing operations: | (22,718) | (25,936) | (21,521) | (3,083) | 413 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (3,083) | 413 | |
| Income (loss) from discontinued operations | 1,199 | 1,164 | (1,730) | ||||
| Other undisclosed net income (loss) | (921) | 1,113 | 6,320 | 203 | |||
| Net income (loss): | (22,440) | (23,658) | (16,930) | (3,083) | 616 | ||
| Other undisclosed net income (loss) attributable to parent | (351) | (560) | 1,037 | 2,363 | |||
| Net income (loss) available to common stockholders, diluted: | (22,791) | (23,658) | (17,490) | (2,046) | 2,979 | ||
Comprehensive Income ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 TTM | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (22,440) | (23,658) | (16,930) | (3,083) | 616 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (22,440) | (23,658) | (16,930) | (3,083) | 616 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.